Literature DB >> 6113840

Haemodynamic effects of cigarette smoking during chronic selective and non-selective beta-adrenoceptor blockade in patients with hypertension.

H Houben, T Thien, A Van 'T Laar.   

Abstract

1 Haemodynamic effects of cigarette smoking before and during chronic treatment with propranolol and metoprolol were studied in 16 patients with essential hypertension. 2 Smoking of cigarettes induced an increase in blood pressure of the same degree in all experimental sessions. Heart rate increased by 16 beats/min during smoking alone, but increased significantly less, when a beta-adrenoceptor blocker was used. Forearm blood flow decreased during smoking in both medication periods. 3 Plasma adrenaline rose significantly during smoking from 0.37 nmol/l to 0.77 nmol/l; plasma noradrenaline did not change. 4 It is concluded that the blood pressure changes induced by smoking are not essentially altered during chronic treatment with selective or non-selective beta-adrenoceptor blockade. Only the increase in heart rate is significantly less pronounced during treatment with both drugs.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6113840      PMCID: PMC1401746          DOI: 10.1111/j.1365-2125.1981.tb01856.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  Direct arterial pressure, heart rate, and electrocardiogram during cigarette smoking in unrestricted patients.

Authors:  G U Cellina; A J Honour; W A Littler
Journal:  Am Heart J       Date:  1975-01       Impact factor: 4.749

2.  Quantitative determination of metoprolol in plasma and urine by gas chromatography.

Authors:  M Ervik
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975

3.  Haemodynamic effects of adrenaline during treatment of hypertensive patients with propranolol and metoprolol.

Authors:  C L van Herwaarden; J F Fennis; R A Binkhorst; A van't Laar
Journal:  Eur J Clin Pharmacol       Date:  1977-12-28       Impact factor: 2.953

4.  Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension.

Authors:  L Hansson; A J Zweifler; S Julius; S N Hunyor
Journal:  Acta Med Scand       Date:  1974 Jul-Aug

5.  [Direct and indirect effects of nicotine on the arterial vascular system].

Authors:  H Klensch
Journal:  Z Kardiol       Date:  1974-06

6.  Smoking and cardiovascular disease. Effect of nicotine on the serum epinephrine and corticoids.

Authors:  P Hill; E L Wynder
Journal:  Am Heart J       Date:  1974-04       Impact factor: 4.749

7.  Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations.

Authors:  R C Tarazi; H P Dustan
Journal:  Am J Cardiol       Date:  1972-05       Impact factor: 2.778

8.  Hemodynamic effects of smoking cigarettes of high and low nicotine content.

Authors:  L Tachmes; R J Fernandez; M A Sackner
Journal:  Chest       Date:  1978-09       Impact factor: 9.410

9.  Determination of adrenaline and noradrenaline in plasma by an isotope derivative method and ion pair liquid chromatography.

Authors:  B M Eriksson; I Andersson; K O Borg; B A Persson
Journal:  Acta Pharm Suec       Date:  1977

10.  Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events.

Authors:  P E Cryer; M W Haymond; J V Santiago; S D Shah
Journal:  N Engl J Med       Date:  1976-09-09       Impact factor: 91.245

View more
  3 in total

1.  Peripheral haemodynamic effects of smoking in habitual smokers. A methodological study.

Authors:  I Berlin; A Cournot; P Renout; J Duchier; M Safar
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Haemodynamic effects of cigarette smoking during beta-adrenoceptor blockade.

Authors:  S Freestone; L E Ramsay
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

3.  Enalapril versus atenolol in the treatment of hypertensive smokers.

Authors:  M Kotamäki; V Manninen; K E Laustiola
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.